Keel Point, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1386935 HUNTSVILLE, AL

Position in REGN

as of Mar 31, 2026 · filed Jun 1, 2026 Compact

Position Value

$297,466

-$121,659 QoQ

Shares Held

385

-29.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 14% Shared 0% None 86%

Healthcare · as of Mar 31, 2026

Keel Point, LLC holds $770,537 across 4 Biotechnology names. REGN ranks #2 (38.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	947	$422,873
2	REGN	Regeneron Pharmaceuticals, Inc. This page	385	$297,466
3	SER	Serina Therapeutics, Inc.	21,508	$41,725
4	GTBP	GT Biopharma, Inc.	20,768	$8,473

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$297,466	385	-29.1%	Shares	Sole	2026-06-01
2025-12-31	$419,125	543	+21.5%	Shares	Sole	2026-02-12
2025-09-30	$251,334	447	+21.5%	Shares	Sole	2025-12-16
2025-03-31	$233,396	368	-9.4%	Shares	Sole	2025-05-15
2024-12-31	$289,205	406	-31.4%	Shares	Sole	2025-02-14
2024-09-30	$622,334	592	0.0%	Shares	Sole	2024-11-14
2024-06-30	$622,209	592	+34.5%	Shares	Sole	2024-08-14
2024-03-31	$423,495	440	+64.2%	Shares	Sole	2024-04-16
2023-12-31	$235,381	268	+1.5%	Shares	Sole	2024-01-30
2023-09-30	$217,261	264	—	Shares	Sole	2023-10-26
No filing history on record for this holder in this stock.